Armata Pharmaceuticals In... (ARMP)
AMEX: ARMP
· Real-Time Price · USD
2.55
0.02 (0.79%)
At close: Aug 15, 2025, 3:56 PM
2.34
-8.24%
After-hours: Aug 15, 2025, 06:13 PM EDT
Armata Pharmaceuticals Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 4.33M | 11.69M | 9.29M | 17.14M | 26.41M | 37.86M | 13.52M | 23.96M | 12.46M | 25.11M | 14.85M | 25.38M | 36.98M | 46.41M | 10.29M | 12.08M | 17.54M | 22.45M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | 5.39M | 5.39M | 5.48M | 5.48M | 5.48M | 5.48M | 5.72M | 5.82M | 5.72M | 5.72M | 5.96M | 5.96M | 5.96M | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 11.23M | 975K | 975K | 11.01M | 1.04M | 2.47M | 2.47M | 8.29M | 8.17M | 8.17M | -9.61M | 6.91M | 7.66M | 7.66M | 2.96M | 2.11M | 2.09M | 2.25M |
Receivables | 2.17M | 238K | 744K | 2.22M | 1.24M | 1.71M | 3.36M | 8.5M | 8.63M | 1.26M | n/a | 1.87M | 1.88M | 1.24M | 2.99M | 1.25M | 1.17M | 1.13M |
Inventory | n/a | n/a | n/a | n/a | n/a | -1.71M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 1.02M | 1.24M | 1.27M | 3.03M | 3.26M | 3.86M | 2.27M | n/a | n/a | 12.23M | 12.2M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Current Assets | 7.52M | 13.17M | 11.31M | 22.39M | 30.9M | 41.72M | 19.15M | 36.59M | 26.83M | 38.59M | 27.05M | 33.24M | 41.31M | 48.7M | 14.99M | 14.18M | 19.71M | 24.04M |
Property-Plant & Equipment | 53.16M | 53.97M | 54.93M | 55.87M | 57.15M | 56.94M | 57.28M | 54.14M | 52.46M | 48.27M | 46.65M | 38.98M | 38.28M | 37.66M | 38.07M | 12.64M | 12.74M | 12.81M |
Goodwill & Intangibles | 3.49M | 13.75M | 13.75M | 3.49M | 13.75M | 13.75M | 13.75M | 13.75M | 13.75M | 13.75M | 13.75M | 13.75M | 13.75M | 13.75M | 13.75M | 13.75M | 13.75M | 13.75M |
Total Long-Term Assets | 73.27M | 74.08M | 75.13M | 75.85M | 77.41M | 78.64M | 90.81M | 76.18M | 74.38M | 70.18M | 68.79M | 59.64M | 59.68M | 59.07M | 54.77M | 28.49M | 28.57M | 28.81M |
Total Assets | 80.79M | 87.25M | 86.44M | 98.24M | 108.31M | 120.36M | 109.96M | 112.76M | 101.21M | 108.78M | 95.83M | 92.88M | 100.98M | 107.77M | 69.77M | 42.67M | 48.28M | 52.84M |
Account Payables | 965K | 981K | 766K | 1.81M | 1.74M | 2.06M | 1.58M | 3.77M | 9.58M | 5M | 1.68M | 2.98M | 4.02M | n/a | 1.14M | n/a | n/a | n/a |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -9.58M | -5M | n/a | -2.98M | -4.02M | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | 83.38M | 102.78M | 38.95M | 107.4M | 111.39M | 96.67M | 9.48M | 13.44M | 26.35M | 45.49M | n/a | 2.22M | 1.71M | 1.52M | n/a | 1.73M | 725K | 724K |
Other Current Liabilities | 35.74M | 1.68M | 529K | 513K | 124K | 322K | -4.85M | -13.44M | n/a | -12.18M | -4.36M | -419K | -50K | 3.19M | n/a | 1.8M | n/a | n/a |
Total Current Liabilities | 120.08M | 110.54M | 48.25M | 118.2M | 123.18M | 110.05M | 16.46M | 21.88M | 51.56M | 51.41M | 24.87M | 7M | 7.38M | 6.23M | 4.81M | 5.25M | 5.9M | 4.98M |
Long-Term Debt | 27.13M | n/a | 55.44M | n/a | n/a | 35.37M | 82.31M | 72.02M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Liabilities | 30.21M | 30.49M | 86.21M | 31.01M | 31.23M | 66.82M | 125.57M | 103.26M | 30.51M | 34.92M | 34.88M | 40.3M | 40.31M | 40M | 39.56M | 13.66M | 13.76M | 13.85M |
Total Liabilities | 150.29M | 141.03M | 134.46M | 149.21M | 154.41M | 176.87M | 142.03M | 125.15M | 82.07M | 86.33M | 59.75M | 47.3M | 47.69M | 46.23M | 44.37M | 18.92M | 19.66M | 18.83M |
Total Debt | 110.51M | 134.66M | 126.52M | 140.33M | 146.14M | 167.91M | 120.37M | 113.63M | 26.35M | 77.33M | 48.81M | 39.45M | 38.94M | 38.44M | 37.99M | 12.31M | 13.07M | 13.11M |
Common Stock | 362K | 362K | 362K | 362K | 362K | 361K | 361K | 361K | 361K | 361K | 361K | 361K | 361K | 361K | 271K | 249K | 249K | 249K |
Retained Earnings | -350.56M | -334.27M | -327.74M | -330.33M | -324.85M | -333.84M | -308.82M | -288.97M | -257.81M | -254.26M | -239.77M | -229.46M | -220.85M | -211.63M | -202.86M | -196.81M | -191.39M | -185.2M |
Comprehensive Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -0.00 | n/a | n/a | 0.00 | n/a | n/a | n/a | n/a | n/a | n/a |
Shareholders Equity | -69.5M | -53.78M | -48.02M | -50.97M | -46.1M | -56.51M | -32.06M | -12.39M | 19.14M | 22.45M | 36.08M | 45.58M | 53.29M | 61.54M | 25.4M | 23.75M | 28.62M | 34.01M |
Total Investments | 5.39M | 5.39M | 5.48M | 5.48M | 5.48M | 5.48M | 5.72M | 5.82M | 5.72M | 5.72M | 5.96M | 5.96M | 5.96M | n/a | n/a | n/a | n/a | n/a |